Angela Timoney

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

Steven Simoens, Brian Godman, Renata Curi Hauegen, 2019, Applied Health Economics and Health Policy.

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Steven Simoens, Brian Godman, Guenka Petrova, 2019, Generics and Biosimilars Initiative Journal.

Establishing data-intensive healthcare: the case of Hospital Electronic Prescribing and Medicines Administration systems in Scotland.

Aziz Sheikh, Kathrin Cresswell, Pam Smith, 2016, Journal of innovation in health informatics.

Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments.

Sarah Kleijnen, H. Leufkens, A. de Boer, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Andy Gray, Brian Godman, Ilse Truter, 2015, Expert review of clinical pharmacology.